Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18INK4C-null reconstituted mice

Cancer Research

Volumn 66, Issue 1, 2006, Pages 343-351

  Yuan, Youzhong ^a   Yu, Hui ^a   Boyer, Matthew J ^a   Song, Xianmin ^a   Cao, Shaonan ^a   Shen, Hongmei ^a   Cheng, Tao ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR P18 INK4C; PROTEIN P18; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; METHYLATION; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECIPIENT; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TISSUE REGENERATION;

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P18; HEMATOPOIETIC STEM CELLS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 31544438803     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2945     Document Type: Article

References (44)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414: 105-11.
2. Warner JK, Wang JC, Hope KJ, Jin L, Dick JE. Concepts of human leukemic development. Oncogene 2004;23: 7164-77.
3. Cheng T. Cell cycle inhibitors in normal and tumor stem cells. Oncogene 2004;23:7256-66.
4. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8.
5. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-5.
6. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
7. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-60.
8. Molofsky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003;425:962-7.
9. Park IK, Qian D. Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;423:302-5.
10. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21(cip1/waf1). Science 2000;287:1804-8.
11. Ellisen LW, Carlesso N, Cheng T, Scadden DT, Haber DA. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J 2001;20: 1897-909.
12. Ezoe S, Matsumura I, Nakata S, et al. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood 2002;100: 3512-20.
13. Qiu J, Takagi Y, Harada J, et al. Regenerative response in ischemic brain restricted by p21cip1/waf1. J Exp Med 2004;199:937-45.
14. Kippin TE, Martens DJ, van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev 2005;19:756-67.
15. Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden D. Stem cell repopulation efficiency but not pool size is governed by p27. Nat Med 2000;6:1235-40.
16. Doetsch F, Verdugo JM, Caille I, et al. Lack of the cell-cycle inhibitor p27Kip1 results in selective increase of transit-amplifying cells for adult neurogenesis. J Neurosci 2002;22:2255-64.
17. Yuan Y, Shen H, Franklin DS, Scadden DT, Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol 2004;6:436-42.
18. Stepanova L, Sorrentino BP. A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. Blood 2005;106:827-32.
19. Yu H, Yuan Y, Shen H, Cheng T. Hematopoietic stem cell exhaustion impacted by p18 and p21 in opposite manners. Blood. Epub 2005 Oct 18.
20. Franklin DS, Godfrey VL, Lee H, et al. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 1998;12:2899-911.
21. Kovalev GI, Franklin DS, Coffield VM, Xiong Y, Su L. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J Immunol 2001;167:3285-92.
22. Bai F, Pei XH, Godfrey VL, Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol 2003;23:1269-77.
23. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000;20:6147-58.
24. Quijano CA, Moore D II, Arthur D, et al. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia. Leukemia 1997;11:1508-15.
25. Cobaleda C, Gutierrez-Cianca N, Perez-Losada J, et al. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood 2000;95:1007-13.
26. Cox CV, Evely RS, Oakhill A, et al. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 2004;104:2919-25.
27. Castor A, Nilsson L, Astrand-Grundstrom I, et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 2005;11: 630-7.
28. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
29. Kerjean A, Vieillefond A, Thiounn N, et al. Bisulfite genomic sequencing of microdissected cells. Nucleic Acids Res 2001;29:E106.
30. Osawa M, Kanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconsutution by a single CD34- low/negative hematopoieutic stem cell. Science 1996;273:242-5.
31. Ema H, Takano H, Sudo K, Nakauchi H. In vitro self-renewal division of hematopoietic stem cells. J Exp Med 2000;192:1281-8.
32. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-806.
33. Knudson AG. Chasing the cancer demon. Annu Rev Genet 2000;34:1-19.
34. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A 2003;100 Suppl 1:11842-9.
35. Perry SS, Wang H, Pierce LJ, et al. L-selectin defines a bone marrow analog to the thymic early T-lineage progenitor. Blood 2004;103:2990-6.
36. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998;12:845-59.
37. Sharpless NE, Bardeesy N, Lee KH, et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001;413:86-91.
38. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-20.
39. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996;85:733-44.
40. Sauvageau G, Iscove NN, Humphries RK. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 2004;23:7223-32.
41. Jordan CT, Guzman ML. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene 2004;23:7178-87.
42. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997;91:661-72.
43. Yang L, Bryder D, Adolfsson J, et al. Identification of Lin-Sca1+kit+CD34+Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated recipients. Blood 2004;105: 2717-23.
44. Allman D, Sambandam A, Kim S, et al. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 2003;4:168-74.